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Abstract.
 
Adult bone tissue is continuously being remodelled and bone mass is main-
tained by a balance between osteoclastic bone resorption and osteoblastic bone formation.
Alteration of osteoblastic cell proliferation may account in part for lack of balance
between these two processes in bone loss of osteoporosis. There is calcium (Ca
 
2
 
+
 
) control
in numerous cellular functions; however, involvement of capacitative Ca
 
2
 
+
 
 entry (CCE)
in proliferation of bone cells is less well investigated. 
 
Objectives
 
: The study described
here was aimed to investigate roles of CCE in the proliferation of osteoblast-like MG-63
cells. 
 
Meterials and Methods
 
: Pharmacological characterizations of CCE were under-
taken in parallel, with evaluation of the expression of transient receptor potential
canonical (TRPC) channels and of cell proliferation. 
 
Results
 
: Intracellular Ca
 
2
 
+
 
 store
depletion by thapsigargin induced CCE in MG-63 cells; this was characterized by a rapid
transient increase of intracellular Ca
 
2
 
+
 
 followed by significant CCE, induced by con-
ditions that stimulated cell proliferation, namely serum and platelet-derived growth factor.
Inhibitors of store-operated Ca
 
2
 
+
 
 channels (2-APB and SKF-96365) prevented CCE,
while voltage-dependent Ca
 
2
 
+
 
 channel blockers had no effect. Expression of various TRPC
channels was shown in the cells, some having been shown to be responsible for CCE.
Voltage-dependent Ca
 
2
 
+
 
 channel blockers had no effect on osteoblast proliferation while
thapsigargin, 2-APB and SKF-96395, inhibited it. Cell cycle analysis showed that 2-APB
and SKF-96395 lengthen the S and G
 
2
 
/M phases, which would account for the reduction
in cell proliferation. 
 
Conclusions
 
: Our results indicate that CCE, likely attributed to the acti-
vation of TRPCs, might be the main route for Ca
 
2
 
+
 
 influx involved in osteoblast proliferation.
INTRODUCTION
 
Bone is a dynamic tissue continuously being remodeled. In the adult, bone mass homeostasis is
maintained locally by a balance between osteoclastic bone resorption and osteoblastic bone
formation. However, in many individuals, bone mass starts falling at midlife, leading to bone loss,
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osteoporosis and debilitating fractures. Both reduced bone formation by osteoblasts and increased
bone resorption by osteoclasts have been associated with the development of osteoporosis.
Osteoblasts ensure bone formation and mineralization through secretion of bone matrix com-
ponents (type I collagen and non-collagenous proteins) and they also provide factors essential
for differentiation of osteoclasts, such as macrophage colony-stimulating factor and receptor
activator of nuclear factor kappa B ligand. By regulating osteoclast differentiation, osteoblasts
play a central role not only in bone formation, but also in maintenance of bone remodeling’s
delicate balance (Mackie 2003). In this regard, adequate osteoblastic proliferation, differentiation,
secretory functions and rate of any apoptosis are essential for both formation and resorption
processes, and thereby bone remodelling equilibrium. Clinical and histomorphometric studies
have demonstrated that ageing is associated with decrease in bone mass and that decreased bone
formation is an important pathogenetic factor (Kragstrup 
 
et al
 
. 1983; Parfitt 1991; Brockstedt
 
et al
 
. 1993). In rodent models of ageing research, studies have indicated a deficit of osteoprogenitor
cells in the bone marrow, and a reduction in the number of osteoblasts (Liang 
 
et al
 
. 1992; Roholl
 
et al
 
. 1994; Quarto 
 
et al
 
. 1995; Bergman 
 
et al
 
. 1996; Kotev-Emeth 
 
et al
 
. 2000; Chen 2004). Similar
observations have been made in humans, showing defects in bone cell proliferation (Pfeilschifter
 
et al
 
. 1993; Kato 
 
et al
 
. 1995; Neidlinger-Wilke 
 
et al
 
. 1995; Bergman 
 
et al
 
. 1996; D’Ippolito 
 
et al
 
.
1999; Martinez 
 
et al
 
. 1999). Moreover, systemic ageing has been associated with decreased
lifespan and accelerated senescence of human bone marrow osteoprogenitors and of osteoblasts
 
in vitro
 
 (Kassem 
 
et al
 
. 1997; Stenderup 
 
et al
 
. 2003; Peterson 
 
et al
 
. 2004). Therefore, during the
ageing process, bone formation is likely to be affected by reduction of osteoblast proliferation,
differentiation and lifespan (Chan & Duque 2002). Osteoporosis research aims to provide novel
understanding of osteoblast proliferation that could provide new therapeutic approaches. 
Calcium (Ca
 
2
 
+
 
) influx is implicated in numerous cellular functions such as protein secretion,
differentiation, apoptosis and more specifically in cell proliferation (Berridge 
 
et al
 
. 2000b). It is
generally accepted that capacitative Ca
 
2
 
+
 
 entry (CCE) is triggered in order to ensure proper
Ca
 
2
 
+
 
 refilling of intracellular stores (Parekh & Putney 2005) and it is thought to be an essential
component of long-term responses of the cell, including proliferation. Activation of capacitative
or store-operated Ca
 
2
 
+
 
 entry (CCE or SOCE) involves first rapid, transient inositol-1,4,5-
trisphosphate (InsP
 
3
 
)-mediated release of Ca
 
2
 
+
 
 from stores, leading to a decrease in Ca
 
2
 
+
 
 con-
centration in the lumen of the endoplasmic reticulum, followed by activation of plasma membrane
Ca
 
2
 
+
 
 channels to generate a sustained influx of Ca
 
2
 
+
 
, CCE. In cells of the osteoblast lineage,
Ca
 
2
 
+
 
 channels have been shown to play fundamental roles in cellular responses to external
stimuli including both mechanical forces and hormonal signals (Duncan 
 
et al
 
. 1998; Iqbal &
Zaidi 2005). Although functional and genetic evidence have argued for the expression of
voltage-dependent Ca
 
2
 
+
 
 channels in osteoblasts, few studies have addressed the importance of
CCE in osteoblastic functions. Wiemann 
 
et al
 
. (1998) first reported CCE in primary cultures
of osteoblasts. Induction of CCE by 1,25(OH)
 
2
 
D
 
3
 
 has been shown in rat osteoblast-like cells
(Baldi 
 
et al
 
. 2002) and, recently, such CCE has been attributed to transient receptor potential
canonical isoform 3 (TRPC3) channels (Baldi 
 
et al
 
. 2003). However, the importance of CCE
in cell proliferation and the expression of other TRPC channels has not been investigated in
osteoblasts. TRPC channels were first identified and characterized in 
 
Drosophila
 
 (Montell &
Rubin 1989) where it forms light-sensitive and Ca
 
2
 
+
 
-permeable channels. Mammalian homologues
have been identified in many non-excitable cells. In general, TRPC channels are considered
non-selective Ca
 
2
 
+
 
-permeable cation channels, although the cation selectivity ratio varies signif-
icantly between different members of the family. TRPC channels have been proposed to encode
components of store-operated Ca
 
2
 
+
 
 channels involved in CCE (Vazquez 
 
et al
 
. 2004) and in cell
proliferation (Golovina 
 
et al
 
. 2001; Sweeney 
 
et al
 
. 2002).
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For this study, we sought to examine the relationship between conditions that stimulate cell
proliferation and CCE in human osteoblast-like MG-63 cells. We conducted measurements of
intracellular Ca
 
2
 
+
 
 and performed pharmacological characterization of Ca
 
2
 
+
 
 signals induced by
conditions shown to stimulate cell proliferation, and investigated TRPC channel expression.
 
MATERIALS AND METHODS
 
Cell culture
 
MG-63 and MC3T3-E1 cell lines were obtained from the American Type Culture Collection
(Rockville, MD, USA) and were grown in Dulbecco’s modified Eagle’s medium-F12 without phenol
(DMEM-F12; Invitrogen, Burlington, Ontario, Canada) and 
 
α
 
-MEM (Invitrogen), respectively,
supplemented with 10% foetal bovine serum (FBS; Cansera, Etobicoke, Ontario, Canada), 2 m
 
m
l
 
-glutamine, 0.1 mg/mL streptomycin, and 100 U/mL penicillin (ICN Biomedicals, Costa Mesa,
CA, USA) at 37 
 
°
 
C in a 5% CO
 
2
 
 humidified atmosphere. Cells were passaged once a week with
the aid of trypsin/EDTA solution (Sigma, Oakville, Ontario, Canada).
 
Measurements of intracellular calcium
 
MG-63 cells were cultured in 4-well Lab-Tek (Nalge Nunc, Naperville, IL, USA) dishes for
5 days, in supplemented media. They were then transferred to HEPES-buffered saline solution
(m
 
m
 
) (121 NaCl, 5.4 KCl, 0.8 MgSO
 
4
 
, 25 HEPES, 1.8 CaCl
 
2
 
 and 6.0 NaHCO
 
3
 
 at pH 7.3) and
loaded with 2 
 
µ
 
m
 
 Fluo-3 acetoxymethyl (Molecular Probes, Eugene, OR, USA) with an equivalent
volume of 20% pluronic F127 (Molecular Probes) for 45 min at 37 
 
°
 
C in the dark. Thereafter,
cells were washed with HEPES-buffered saline solution and loaded dye was allowed to
de-esterify for 45 min at room temperature in the dark. Following transfer to a Ca
 
2
 
+
 
-free solution
(HEPES-buffered saline solution without CaCl
 
2
 
), additions were made in an open chamber
configuration at room temperature. Cells were examined using a laser scanning confocal
(Bio-Rad Laboratories, Hercules, CA, USA) microscope (Nikon TE300, Tokyo, Japan) with an
Apochromatic 40X N.A. 1.0 objective lens. Fluorescence was excited by an argon laser at 488 nm
and emission was collected with a 515 filter. Release of Ca
 
2
 
+
 
 from endoplasmic reticulum was
induced by addition of 5 
 
µ
 
m thapsigargin (Tg) (Sigma). Following addition of Ca2+ to the buffer
(final concentration of 1.8 mm), a store-operated influx could be obtained. Inhibition of store-
operated channels was accomplished by addition of 1-{β-[3-(4-methoxyphenyl)propoxy]-4-
methoxyphenethy}-1H-imidazole hydrochloride (SKF-96365) or 2-aminoethoxydiphenylborate
(2-APB) before addition of Ca2+ to the media. Data were analysed with Laser Sharp 2.1T,
Time Course 1.0 software (Hemel Hempstead, UK). The area under the curve was computed
using GraphPad Prism version 4.00 for Macintosh (GraphPad Software, San Diego, CA, USA).
Cell proliferation
Cells were seeded at 2000 cells/cm2 and were cultured for 3 days in supplemented DMEM-F12.
To evaluate serum-regulated proliferation, cells in 24-well plates (Sarstedt, Montréal, Québec,
Canada) were incubated with or without 10% FBS until day 7 and cell counts were performed
on trypsinized cells at different intervals of time. Otherwise, cell proliferation was determined
in 96-well plates (Sarstedt) using the microtiter tetrazolium (MTT) assay after 24 or 48 h of
treatment. Briefly, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrasodium bromide (MTT, Sigma)
was added to the media at a final concentration of 0.5 mg/mL. Four hours later, formazan crystals
generated by cellular reduction of the MTT reagent were dissolved in dimethyl sulfoxide
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(Sigma) for 30 min at 37 °C and absorbance was determined at 575 nm. Results are expressed
as the percentage of MTT values of treated versus control conditions for which initial MTT
[absorbance values of the initial day of treatment (MTTi)] were subtracted according to the equation:
Cell proliferation (%) = [(OD575nm treated – MTTi)/(OD575nm control – MTTi)] × 100.
Cell cycle analysis
MG-63 cells were cultured in 100 mm dishes (Sarstedt) and were incubated with Ca2+ channel
blockers or appropriate vehicle substance. They were fixed overnight in 70% ethanol and
incubated at 37 °C for 30 min in phosphate-buffered saline (PBS; 2.7 mm KCl, 1.4 mm KH2PO4,
0.5 mm MgCl2, 140 mm NaCl et 10 mm Na2HPO4 at pH 7.4) containing 1.12% citrate with 125
U RNase (GE Healthcare, Baie d’Urfé, Québec, Canada). Cells were then incubated for 1 h with
12.5 µg propidium iodide (PI) (Sigma) and data were acquired by a FACScan flow cytometer
(Becton Dickinson, Mountain View, CA, USA) using CellQuest software and analysed with the
ModFit LT version 3.0 software (Verity Software House Inc., Topsham, ME, USA).
Determination of expression of TRPC and voltage-dependent Ca2+ channel by reverse 
transcription-polymerase chain reaction
Total RNA was extracted using Trizol (Invitrogen) according to the manufacturer’s instructions.
Complementary DNA was synthesized using Omniscript reverse transcription (RT) kit (Qiagen,
Mississauga, Ontario, Canada) with random hexamer primers. Oligonucleotide primers for
polymerase chain reaction (PCR) were designed from coding regions of human TRPC channels
and voltage-dependent Ca2+ channels (VDCC) and special care was paid that complementary
sequences were in different exons (Tables 1 and 2). PCRs were performed with a MultiGene
thermal cycler (Labnet, IR System, Edison, NJ, USA) using the Taq PCR core kit (Qiagen). The
mixture was initially denatured at 94 °C (3 min) followed by 40 cycles consisting in denaturation
at 94 °C (1 min), annealing at 58 °C (30 s) and extension at 72 °C (1 min). PCR products were
subjected to electrophoresis on 2% agarose gel and amplicons were visualized by ethidium bromide
staining. Cleavage of amplicons by restriction enzymes was used to confirm the specificity of
the PCR amplifications.
Western blot analysis
To prepare crude membranes, cells were retrieved in ice-cold hypotonic lysis buffer (10 mm
NaCl, 10 mm Tris pH 7.4, 1 mm EDTA and 3 mm MgCl2) containing protease inhibitors (1 mm
Table 1. Primer sequences for the detection of transient receptor potential canonical (TRPC) channel by RT-PCR
Gene
Accession 
number
Primer 
orientation Primer sequence
Product size 
(bp)
Location 
in sequence
hTRPC1 NM_003304 Sens 5′-GTTTCATGATTTTGCTGATCGGA-3′ 472 1472–1493
Antisens 5′-AGCACAATCACAACCACGACATT-3′ 1924–1944
hTRPC3 NM_003305 Sens 5′-TCCAAGACGCTGAACGTCAAC-3′ 404 608–628
Antisens 5′-CACTTGCAGAAATAGTCGTGCG-3′ 990–1011
hTRPC4 NM_016179 Sens 5′-AGAAGTCGTCGGAGCTGTTGAG-3′ 1211 549–570
Antisens 5′-CCAGAGATATTTGCAGAGGTCCC-3′ 1737–1759
hTRPC6 NM_004621 Sens 5′-AGAAGGGGAGAAGGTTAGCTAATCG-3′ 692 648–671
Antisens 5′-CAGTTCATTGCTAAGTTCTAAAGCCG-3′ 1324–1339
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Na2VO3, 0.1 mm phenylmethylsulphonyl fluoride, 5 µg/mL leupeptin, 0.5 mm benzamidine,
5 µg/mL aprotinin and 1 mm dithiothreitol), homogenized with a Teflon-glass homogenizer
and were centrifuged at 10 000 g. Supernatants were then centrifuged at 100 000 g for 1 h and
pellets were re-suspended in buffer containing 1% Triton, 150 mm NaCl, 50 mm Tris pH 7.4,
1 mm EDTA, 0.5% Nonidet P-40 and 60 mm octylglucoside with protease inhibitors. Protein
concentration was determined by a MicroBCA protein assay (Pierce, Rockford, IL, USA).
Proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (7.5%
polyacrylamide gel) and were transferred to polyvinylidene difluoride membranes (NEN Life
Science Products Inc., Boston, MA, USA). After overnight incubation at 4 °C with 2% blocking
agent (GE Healthcare) in Tris-buffered saline and 0.1% Tween-20 (TBS-T), polyvinylidene
difluoride membranes were incubated with affinity-purified polyclonal antibodies specific for
various TRPC channels (Chemicon, Temecula, CA, USA; Ab-5446 for TRPC1, Ab-5576 for
TRPC3, Ab-5812 for TRPC4 and Ab-5574 for TRPC6) at room temperature. Membranes were
then washed with TBS-T, were incubated with antirabbit horseradish peroxidase-conjugated
immunoglobulin G and immunoreactive proteins were revealed by enhanced luminol-linked
chemiluminescence detection system (ECL Advance, GE Healthcare). Human brain cell lysate
(Calbiochem, La Jolla, CA, USA) was used as positive control for specificity of the antibodies.
Also, immunodetection with TRPC antibodies pre-incubated with the antigen was used to ascer-
tain the specificity of the detected TRPC bands.
Statistical analysis
Statistical comparisons were performed using anova or Student’s t-test (using GraphPad Prism
version 3.02). Differences were considered to be significant when P < 0.05.
RESULTS
Stimulation of CCE by thapsigargin-induced store depletion
In order to assess the presence of CCE in human osteoblast-like MG-63 cells, we performed
fluorescence measurements of intracellular Ca2+ from MG-63 cells loaded with Fluo-3
acetoxymethyl. The fluorescence of 30–40 cells per field was analysed. The individual fluorescence
Table 2. Primer sequences for the detection of voltage-dependent Ca2+ channel by RT-PCR
Gene
Accession 
number
Primer 
orientation Primer sequence
Product size 
(bp)
Location 
in sequence
α1D NM_000720 Sens 5′-TGCAAGATGACGAGCCTGAG-3′ 245 5163–5182
Antisens 5′-ATGGTTATGATGGTTATGACAC-3′ 5386–5407
α1C NM_000719 Sens 5′-CTACCCCAGCACGGTCAGCAC-3′ 437 5614–5634
Antisens 5′-CCTGATGATGAACCAGATGCAAG-3′ 6028–6050
α1B NM_000718 Sens 5′-CTCATCCTCCTCCTCGGAGAAG-3′ 607 6496–6517
Antisens 5′-GTCCCAGGGTGCAGTGGTAAC-3′ 7083–7103
α1A NM_000068 Sens 5′-CTGATGCTGAATCTCTTTGTCGC-3′ 512 5683–5705
Antisens 5′-CAGTTCATTGCTAAGTTCTAAAGCCG-3′ 6174–6194
α1E NM_000721 Sens 5′-ACCTTGTTTGGCAACTACACGC-3′ 792 2224–2245
Antisens 5′-TTCATCCAGACTGCGTTCCTG-3′ 2995–3015
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intensities of treated cells were compared to the fluorescence intensity before the stimulation and
were used to obtain a mean fluorescence ratio for each experiment. Thapsigargin is an inhibitor
of endoplasmic reticulum Ca2+-ATPase and in the absence of external Ca2+, 5 µm Tg induced a
transient increase in intracellular Ca2+ concentration ([Ca2+]i) (Fig. 1), which corresponds to the
classical depletion of intracellular Ca2+ stores. When extracellular Ca2+ was reintroduced, a rapid
rise in Ca2+ was evoked, which is typical of CCE. In contrast, the cells showed no response to
addition of 1.8 mm Ca2+ in the buffer without prior stimulation with Tg (Fig. 1, inset), suggesting
no significant Ca2+ influx following the addition of Ca2+ at basal conditions. The majority of
cells (77–98%) responded to the addition of Tg and Ca2+. In order to confirm activation of CCE,
we used two well-known inhibitors of store-operated Ca2+ entry, namely 2-APB and SKF-96365.
Following Ca2+ store depletion with 5 µm Tg in the absence of extracellular Ca2+, addition of
1.8 mm Ca2+ and 100 µm 2-APB to the incubation media strongly reduced Ca2+ entry – by
87.3 ± 9.6% (Fig. 1) (Dunnett’s t-test; P < 0.01). Furthermore, similar reduction of CCE was
observed in the presence of 30 µm SKF-96365 (86.8 ± 5.4%) (Dunnett’s t-test; P < 0.01). No
significant difference was demonstrated for the percentage of cells that responded to Tg in
the presence of channel blockers. In contrast, verapamil, a VDCC antagonist, had no effect on
Tg-induced CCE (data not shown). Altogether, these results reveal the presence of CCE in
MG-63 cells and the efficiency of 2-APB and SKF-96365 to inhibit Ca2+ entry.
Cell proliferation and CCE induced by serum and platelet-derived growth factor-BB
In order to evaluate the roles of CCE in MG-63 cells, we first determined conditions that
stimulate cell proliferation. We performed cell counts over a 7-day culture period with or without
FBS (Fig. 2a). A typical exponential growth curve was observed for cells cultured in media
supplemented with 10% FBS, resulting in a doubling time of approximately 28 h. Cell proliferation
was almost completely prevented in serum-free medium for the last 4 days of culture, with a cell
doubling time of approximately 60 h. As shown in Fig. 2b, cell proliferation was also stimulated
Figure 1. Induction of capacitative calcium (Ca2+) entry in MG-63 cells. Fluo-3-loaded cells were treated with 5 µm
thapsigargin (Tg) in Ca2+-free HEPES-buffered saline solution. After agonist-mediated intracellular Ca2+ release, Ca2+
(final concentration of 1.8 mm, right arrow) were introduced into the buffer alone () or in the presence of () 2-APB
(100 µm) or () SKF-96365 (30 µm). Each response shown is from at least three experiments with cumulative analysis
of between 30 and 40 cells per field. Inset: addition of calcium to Ca2+-free HEPES-buffered saline solution without
prior incubation with Tg.
872 D. Labelle et al.
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cell Proliferation, 40, 866–884.
by platelet-derived growth factor-BB (PDGF-BB) with an EC50 of 9 ng/mL and 85% stimulation
was reached at 25 ng/mL. The subsequent experiments were therefore conducted after 5 days of
culture in media supplemented with 10% FBS or 25 ng/mL PDGF-BB.
We investigated cellular Ca2+ signals induced by factors that stimulate MG-63 cell proliferation.
As shown in Fig. 3, PDGF-BB induced a rapid transient increase of [Ca2+]i followed by a
sustained influx following Ca2+ addition in the incubation medium. The increase in [Ca2+]i
following addition of extracellular Ca2+ was prevented by 2-APB and SKF-96365 (Fig. 3)
(Dunnett’s t-test; P < 0.01) indicating that stimulation of the cells by PDGF-BB is associated
with the induction of CCE. A similar response was obtained when cells were stimulated with 10%
FBS and serum-induced CCE was also inhibited by store-operated Ca2+ channel (SOCC) blockers
(data not shown). Verapamil had no effect on PDGF-induced CCE (Fig. 3, inset). Furthermore,
the rapid Ca2+ spike induced by PDGF-BB was abolished when thapsigargin-sensitive stores
were depleted before addition of growth factors (data not shown) indicating the solicitation of
identical intracellular Ca2+ stores.
Figure 2. Cell proliferation induced by foetal bovine serum (FBS) and platelet-derived growth factor-BB (PDGF-
BB). Cells were seeded with DMEM-F12 containing 10% FBS at 2000 cells/cm2 in 24-well plates (for cell counts) or
96-well plates (for MTT assay). (a) At day 3 of culture, cells were incubated in supplemented DMEM-F12 with or with-
out 10% FBS until day 7 and media were refreshed at day 5. Counts were performed in triplicate on trypsinized cells
from 4 to 6 separate cultures and data are mean ± SEM (two-way anova; P < 0.004). (b) After 4 days of culture, cells
were serum-starved for 24 h and were incubated for 48 h in DMEM-F12 without FBS and with increasing concentra-
tions of PDGF-BB. Cell proliferation was determined by MTT assay and data are expressed as the mean ± SEM of per-
centage of control conditions without growth factors from four individual experiments (anova; P < 0.0001, Dunnett’s
t-test; P < 0.01 from 7.5 ng/mL).
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Expression of VDCCs and TRPC channels
Because TRPC channels have been associated with CCE (Birnbaumer et al. 1996; Berridge
et al. 2000a), we sought to determine expression of such channels in MG-63 cells. Messenger
RNA for TRPC1, TRPC3, as well as TRPC4 and TRPC6 were revealed by RT-PCR (Fig. 4a).
Interestingly, amplification with primers for TRPC4 showed three major bands that likely
correspond to different splicing variants previously reported as TRPC4 and α, β, ε (1200 bp,
NM_016179, AF421358, AF421359, AF421360), TRPC4η (900 bp, AF421361), TRPC4ζ
(700 bp, AF421362). Genetic expression of TRPC5 and TRPC7 were not revealed here by
RT-PCR using total or messenger RNA.
TRPC1, TRPC3 and TRPC4 proteins were detected in crude membrane extracts from MG-
63 cells (Fig. 4b, bottom). TRPC1 immunodetection revealed the presence of an 85–90 kDa
band. An 85–90 kDa band was also revealed in the human brain cell extract that was consistent
with protein weight reported in literature. TRPC3 immunodetection showed a single-specific
band at 95 kDa that was consistent with the predicted weight between 85 and 115 kDa for
non-glycosylated TRPC3 protein and protein glucosylated to various degrees (Fig. 4b). Further-
more, TRPC4 immunodetection revealed the presence of three different bands that could rep-
resent protein isoforms corresponding to splice variants that we previously revealed by RT-PCR.
Unfortunately, TRPC6 protein could not be detected in MG-63 cells and may indicate that the
protein level was beneath our limit of detection.
Because VDCCs have been shown to be involved in osteoblastic functions (Guggino et al.
1989; Moreau et al. 1996, 1997; Bergh et al. 2004), we evaluated the genetic expression
of VDCC in MG-63 cells. As shown in Fig. 4c, presence of messenger RNAs for L-type
(neuroendocrine α1C, 437 bp; cardiac α1D, 245 bp), for N-type (α1B, 607 bp), for P/Q-type (α1A,
512 bp) and for R-type (α1E) VDCC was revealed by RT-PCR. No expression for the L-type
skeletal isoform (α1S) was revealed. Expression of T-type VDCC was not investigated.
Figure 3. Capacitative calcium (Ca2+) entry induced by platelet-derived growth factor-BB (PDGF-BB). Fluo-3-
loaded cells were treated with 25 ng/mL PDGF-BB in HEPES-buffered saline solution and intracellular Ca2+ measure-
ments were performed without () or with () 100 µm 2-APB and () 30 µm SKF-96365. Each response shown is rep-
resentative of four experiments cumulating analysis of between 30 and 40 cells per field. Inset: representative data of
intracellular Ca2+ measurement from cells stimulated with 25 ng/mL PDGF-BB in the presence of 100 µm verapamil.
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Moreover, addition of the agonist of L-type VDCC, BayK 8644, led to an increase in [Ca2+]i that
was prevented by the L-type VDCC antagonist verapamil (Fig. 4d) confirming the expression
and activity of VDCC.
Implication of Ca2+ influx in MG-63 cell proliferation
We first determined the effect of Tg-mediated intracellular Ca2+ store depletion on proliferation
of MG-63 cells. As shown in Fig. 5, low concentrations of Tg significantly reduced this cell
proliferation of after 48 h of incubation (anova; P < 0.0001; Dunnett’s t-test; P < 0.001 from
0.005 µm) and further impaired cell survival from 0.1 µm (Tukey’s test; P < 0.05, compared to
100.3 ± 6.6 µm for initial MTT) and higher concentrations. To characterize Ca2+ influx involved
in proliferation, it was evaluated in the presence of different Ca2+ channel blockers. Cells were
incubated for 24 or 48 h in the presence of 10% FBS with increasing concentrations of VDCC
blockers (verapamil and nifedipine). These blockers exerted no significant effect on serum-
mediated cell proliferation even at the highest concentrations used (Fig. 6a,b). We then evaluated
Figure 4. Expression of transient receptor potential canonical (TRPC) and voltage-dependent Ca2+ channel
(VDCC) in MG-63 cells. (a) Total RNA from MG-63 cells was used for RT-PCR with specific primers for TRPC.
Amplicons were revealed by 2% agarose gel electrophoresis and are representative results from at least three experiments. (L:
100 bp marker). (b) Protein extracts from human brain cell lysate or MG-63 cells were subjected to SDS-PAGE on 7.5%
acrylamide gel. Proteins were electrotransfered on polyvinylidene difluoride membranes and immunodetection was per-
formed as described in the materials and methods section. (c) Total RNA from MG-63 cells was used for RT-PCR with
specific primers for L-type (neuroendocrine α1D and cardiac α1C isoforms), N-type (α1B), P/Q-type (α1A) and R-type
(α1E) VDCC. Amplicons were revealed by 2% agarose gel electrophoresis and are representative results from at least
three experiments. (L: 100 bp marker). (d) Fluo-3-loaded cells were treated with 50 µm BayK 8644 without or with
100 µm verapamil in HEPES-buffered saline solution and intracellular Ca2+ measurements were performed.
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effects of well-known SOCC inhibitors, 2-APB and SKF-96365. As shown in Fig. 6c,d, both inhibitors
decreased MG-63 proliferation in a dose- and time-dependent manner. When the cells were
cultured for 48 h in the presence of 100 µm 2-APB, a significant decrease in cell proliferation
was observed, reaching 55% (Fig. 6c). In the presence of 20 µm SKF-96365, strong inhibition
(90%) of cell proliferation was also observed at 48 h (Fig. 6d). Moreover, proliferation of
non-transformed MC3T3-E1 murine osteoblastic cells was also prevented by 100 µm 2-APB and
Figure 5. Effect of thapsigargin on the proliferation and survival of MG-63 cells. Cells were incubated with
increasing concentrations of thapsigargin (Tg) for 24 and 48 h in DMEM-F12 supplemented with 10% foetal bovine
serum. Cell proliferation was determined by MTT assay and data are the mean ± SEM of percentage of cell proliferation
from three independent experiments.
Figure 6. Effect of calcium channel blockers on cell proliferation induced by serum. Osteoblasts were cultured for 24 h
() or 48 h ( ) in DMEM-F12 supplemented with 10% FBS and increasing concentrations of (a) verapamil, (b) nifedipine
(c) 2-APB (d) SKF-96365 or vehicle alone (control). Cell proliferation was determined by MTT assay and data are the
mean ± SEM of the percentage of cell proliferation from three to six independent experiments (anova; P < 0.001,
Dunnett’s t-test; aP < 0.05; bP < 0.01; cP < 0.001 compared to control for the same incubation period).
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10 µm SKF-96365 (relative proliferation to control: 1.75 ± 0.04 versus 1.36 ± 0.27 and 1.04 ± 0.15
with 2-APB and SKF-96365, respectively), whereas 67 µm verapamil had no effect (1.75 ± 0.04
versus 1.88 ± 0.11 with verapamil). Furthermore, VDCC blockers were without effect on cell
proliferation induced by PDGF-BB (Fig. 7), while both 2-APB and SKF-96365 inhibited PDGF-
induced MG-63 cell proliferation.
Although significant cytotoxicity with SOCC blockers was not seen under our experimental
conditions, we evaluated the effect of SKF-96365 under culture conditions without serum or
PDGF-BB, where cells have a reduced rate of proliferation, in order to establish the specific
effect of the SKF-96365 on this parameter. At a concentration of 10 µm, SKF-96365 caused
significant inhibition of cell population growth by 80% in the presence of 10% FBS (1.76 ± 0.11
versus 1.15 ± 0.05 with SKF-96365), while it had no significant effect under low cell proliferation
rates in serum-free conditions (1.21 ± 0.05 versus 1.07 ± 0.10 with SKF-96365). Moreover,
50 µm 2-APB had no significant effect in the absence of serum (1.08 ± 0.04 versus 1.02 ± 0.05
with 2-APB). Because reduction of osteoblast proliferation may promote differentiation, we
determined alkaline phosphatase acitivity, a well-known osteoblastic marker. The alkaline
phosphatase activity of MG-63 cells was not significantly different in the presence of 10 µm
SKF-96365 (63.0 ± 13.1 versus control 75.1 ± 3.0 nmol PNP/mg protein/1 h) indicating that
inhibitors of CCE did not promote osteoblastic differentiation nor did they impair cell viability.
Some studies have reported potential side effects of SKF-96365, not attributable to its
inhibition of Ca2+ influx; it has been reported to modulate prostaglandin E2 (PGE2) pathway
acting as an inhibitor of cyclooxygenase (Leis et al. 1995). Therefore, we investigated whether
inhibition of cell proliferation by SKF-96365 resulted from reduction of PGE2 production, using
the cyclooxygenase inhibitor indomethacin. Treatment of MG-63 cells with indomethacin had
no significant effect on cell proliferation and survival (OD575nm of 0.61 ± 0.18 in the presence
of 30 µm indomethacin versus control 0.63 ± 0.16) indicating that the antiproliferative effect of
SKF-96365 was not related to the reduction of PGE2 synthesis. Compounds related to SKF-
96365 such as imidazole antimycotics, econazole and miconazole, have been used as potent
inhibitors of cytochrome P450 and CCE, leading to the proposed involvement of cytochrome
Figure 7. Effect of calcium channel blockers on MG-63 proliferation induced by platelet-derived growth factor-
BB (PDGF-BB). Cells were incubated for 48 h in supplemented DMEM-F12 containing 25 ng/mL PDGF-BB in the
absence or presence of 100 µm verapamil, 100 µm 2-APB or 10 µm SKF-96365. Cell proliferation was measured by
MTT assay and data are expressed as mean ± SEM of percentage of the control without PDGF. Student’s t-test;
aP < 0.001 compared to PDGF alone.
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P450 in CCE (Alvarez et al. 1992). In order to determine the involvement of cytochrome P450
inhibition in the reduction of cell proliferation by SKF-96365, we evaluated cell proliferation
in the presence of non-imidazole inhibitor of cytochrome P450, SKF-525 A. MG-63 cell
proliferation was not affected by SKF-525 A (OD575nm of 1.37 ± 0.32 in the presence of 50 µm
SKF-525 A versus control 1.15 ± 0.18) indicating that inhibition of cytochrome P450 was not
responsible for the observed prevention of cell proliferation by SKF-96365.
Effect of capacitative Ca2+ channel blockers on the cell cycle
Because we observed that 2-APB and SKF-96365 inhibit osteoblastic cell proliferation, we
investigated the effect of such blockers on the progression of cell cycle. Our results show that
2-APB and SKF-96365 had similar effects. Treatments for 4 h with either 50 µm 2-APB or 5 µm
SKF-96365 reduced cell numbers in G0/G1 phase, and increased proportion of cells in S and
G2/M phases (Fig. 8). After 24 h, treatment with both antagonists also resulted in augmentation
of the proportion of cells in S and G2/M phases. This effect was also perceptible using confocal
microscopy following PI staining where we observed many cells with double DNA content
(data not shown). Taken together, these results suggest that SOCC blockers lengthen S and
G2/M phases rather than arresting the cell cycle.
DISCUSSION
In the current study, we show that depletion of internal Ca2+ stores and inhibition of CCE
prevented MG-63 cell proliferation while inhibition of VDCC was without effect. Moreover, for
the first time we have demonstrated expression of TRPC1, 3, 4 and 6 in the human osteoblast-like
MG-63 cells. Our results support an important role of capacitative Ca2+ influx, more likely
attributable to TRPC channels, in the proliferation of osteoblastic cells.
Figure 8. Effect of 2-APB and SKF-96365 on the cell cycle. Cells were incubated with 50 µm 2-APB, 5 µm SKF-
96365 or vehicle alone for 4 h or 24 h in supplemented DMEM-F12 media containing 10% FBS (control of 24 h). Cells
were re-suspended and stained with PI as described in the materials and methods section. Cells were then analysed using
a FACScan flow cytometer. Profiles of DNA content are representative results from three independent experiments.
Student’s t-test; aP < 0.05, bP < 0.03 and cP < 0.006 when compared to G0/G1 from the control; 
dP < 0.03, eP < 0.003
and fP < 0.006 when compared to S and  G2/M from the control.
878 D. Labelle et al.
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Cell Proliferation, 40, 866–884.
Treatment of MG-63 cells with Tg in Ca2+-free buffer led to depletion of internal Ca2+ stores
with concomitant stimulation of CCE observed by addition of extracellular Ca2+. Such CCE
has been reported in primary cultures of rat osteoblast cells (Wiemann et al. 1998) and in rat
osteoblast-like ROS 17/2.8 cells (Baldi et al. 2002). Capacitative Ca2+ influx was not prevented
by VDCC inhibitors, suggesting that the latter channels were not solicited. CCE was prevented
by SKF-96365 and 2-APB, which argues for the involvement of SOCC. 2-APB has been shown to
inhibit sarco/endoplasmic reticulum Ca2+-ATPase and InsP3 receptors (Bilmen & Michelangeli
2002; Bilmen et al. 2002). Inhibition of sarco/endoplasmic reticulum Ca2+-ATPase by 2-APB
would lead to a Ca2+ release from intracellular stores, an effect that was not seen in MG-63 cells
with the concentrations used. Furthermore, inhibition of InsP3 receptors by 2-APB would
prevent thapsigargin-mediated Ca2+ release from intracellular stores, an effect that was not
seen under our experimental conditions. Our results demonstrate that MG-63 cells exhibit CCE
induced by internal Ca2+ store depletion and that this Ca2+ influx is completely inhibited by
SOCC blockers such as 2-APB and SKF-96365. A variety of mitogenic agents stimulate cell
population growth by increasing [Ca2+]i. Our results indicate that growth factors from serum and
PDGF-BB induced an initial Ca+ release from Tg-sensitive internal stores in MG-63 cells that
is followed by CCE. Previous addition of Tg in Ca2+-free buffer prevents initial intracellular Ca2+
increase induced by serum and PDGF-BB, indicating solicitation of similar internal stores.
Sandy et al. (1998) reported that serum and PDGF induced IP3 synthesis in MG-63 cells. Inositol
production, following growth factor activation of tyrosine kinase receptors in osteoblasts, has
been related to activation of phospholipase C gamma (Bornfeldt et al. 1995). Such IP3 production
with subsequent depletion of IP3-sensitive internal Ca
2+ stores is a prerequisite for activation of
CCE (Zitt et al. 2002).
Because Ca2+ signals are involved in numerous cell functions, we investigated the effect of
different Ca2+ channel inhibitors on MG-63 cell proliferation. The cells showed a doubling time
of approximately 28 h in the presence of 10% FBS that is consistent with observations of Mohiti
et al. (1997). In the absence of serum, they pursue their basal level of proliferation but with a
population doubling time of 60 h. In addition, PDGF-BB also stimulated cell proliferation.
Under serum- or PDGF-mediated proliferation conditions, VDCC blockers had no significant
effect on proliferation levels, indicating that Ca2+ influx through L-type VDCC is not involved
or has only a minor contribution to serum- or PDGF-induced cell proliferation. Similar results
were obtained with non-transformed MC3T3 murine osteoblastic cells. In contrast, Kim et al.
(1991) reported that verapamil inhibits MC3T3 DNA synthesis and decreased cell proliferation.
However, other studies reported that VDCC blockers were without effect on MC3T3 cell pro-
liferation (Sugimoto et al. 1994). Interestingly, verapamil was shown to inhibit cell proliferation
of electrically stimulated MC3T3 cells but not cell proliferation under control conditions (Lorich
et al. 1998). The discrepancy concerning the effect of Verapamil may correspond to stimu-
lation conditions and factors involved. Activation of L-type VDCC has been reported for oste-
oblastic responses to external stimuli and mechanical stress. Accordingly, expression of VDCC,
both L-type and non-L-type isoforms (P/Q, N, R, T) has been demonstrated in osteoblasts (Barry
2000), and we confirmed expression and activity of VDCC in MG-63 cells. Parathyroid hormone
and PGE2 triggered an initial L-type-mediated Ca
2+ influx in the MG-63 cells that subsequently
resulted in activation of potassium channels (Moreau et al. 1996). Calcitonin gene-related
peptide stimulates a cyclic adenosine monophosphate-dependent Ca2+ influx that is inhibited by
L-type VDCC blocker verapamil (Burns et al. 2004). Fluorescence monitoring of intracellular
Ca2+ concentrations indicated that L-type VDCC are important in early mechanical stress trans-
duction in primary osteoblasts from rat femora (Walker et al. 2000) and in murine osteoblasts
MC3T3-E1 (Genetos et al. 2005). Moreover, a range of studies has indicated that Ca2+ influx via
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L-type VDCC is involved in synthesis and secretion of various bone proteins such as osteocalcin,
osteopontin and osteoprotegerin (Guggino et al. 1989; Moreau et al. 1997; You et al. 2001;
Bergh et al. 2004). It should be noted that verapamil and nifedipine strongly inhibit L-type
channel at low concentrations while at high concentrations, these two blockers also inhibit
non-L-type currents (Diochot et al. 1995). Because our results have indicated that high
concentrations of VDCC blockers had no effect on MG-63 cell proliferation, it is more likely
that VDCC, both L-type and non-L-type, play a minimal role in osteoblast proliferation. In that
respect, voltage-dependent Ca2+ currents identified in osteoblasts are more likely to be
implicated in synthesis and secretion of bone specific proteins with functional contributions in
bone remodeling.
On the other hand, MG-63 cell population growth was reduced by inhibition of CCE with
2-APB and SKF-96365. Concentrations of SOCC blockers exerting a significant effect on
MG-63 cell proliferation were consistent with concentrations shown to inhibit serum- and PDGF-
induced CCE under our experimental conditions. Furthermore, previous studies have reported
significant inhibition of cell proliferation by 2-APB and SKF-96365 at concentrations of 30–100
µm and of 1–20 µm, respectively, depending on cell type (Magnier-Gaubil et al. 1996; Sugioka
et al. 1999; Enfissi et al. 2004). It should be noted that 2-APB and SKF-96365 had no significant
effect on cells in the absence of serum or PDGF, suggesting that capacitative current is mainly
triggered by growth factors and that SKF-96365 had no side effect and did not induce apoptosis
in growth arrested cells.
Unfortunately, blockers tend to be selective for a group rather than specific to one type of
channel and side effects are often reported. Leis et al. (1995) reported that SKF-96365 impairs
the PGE2 pathway. The latter has been reported to induce osteoblast proliferation (Conconi
et al. 2002; Tsai et al. 2004; Ghayor et al. 2005). Treatments of MG-63 cells with concentra-
tions up to 30 µm indomethacin, a cyclooxygenase inhibitor, showed no significant effect on cell
proliferation indicating that the PGE2 pathway was not implicated in proliferation of MG-63
cells under our conditions. Moreover, imidazole antimycotics such as econazole and miconazole
are potent inhibitors of cytochrome P450 and have been associated with inhibition of CCE
(Alvarez et al. 1992). Our results indicate that non-imidazole cytochrome P450 inhibitor SKF-
525 A did not affect MG-63 cell proliferation, demonstrating that potential inhibition of cyto-
chrome P450 by SKF-96365 did not account for prevention of cell proliferation. Therefore, the
inhibition of proliferation by the SKF-96365 in our experiments is more likely due to inhibition
of SOCC-dependent Ca2+ entry. Interestingly, 2-APB was less efficient than SKF-96365 to
inhibit proliferation of MG-63 cells. It should be noted that 2-APB has also been shown to
activate TRPV5 and TRPV6, two highly Ca2+-selective channels (Hu et al. 2004). Expression
of TRPV channels has not yet been investigated in osteoblasts.
Maintenance of a sufficient reserve of Ca2+ in the endoplasmic reticulum is critical for normal
cell function and these reserves are needed at least for progression of cells through the cell cycle
(Takuwa et al. 1995). Our data showed that treatment with 50 µm 2-APB or 5 µm SKF-96365
resulted in reduction of cell number in G0/G1 phase, and an increase in the proportion of cells in
S and G2/M phases (Fig. 8). Although Mitsui-Saito et al. (2000) showed, in vitro, polymerization
inhibition of microtubule protein isolated from bovine brain by SKF-96365 that could result in
mitotic spindle dysfunction and G2/M arrest, concentrations used in our cell cycle assay are
lower than those used in their study. Moreover, we report that 2-APB also affects cell cycle
progression of MG-63 cells although no alteration in microtubule dynamics has been reported for
2-APB. Calmodulin, an intracellular Ca2+ binding protein, may regulate cell cycle phase tran-
sitions, affects the activation state of cyclin-dependent kinase (cdk) complexes and cytokinesis
(Kahl & Means 2003). Further studies on the effect of SOCC blockers on cdk/cyclin functions,
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and on the duration of cell cycle phases are essential to reveal the SOCC blocker mechanism
related to cell cycle lengthening.
Our results indicate for the first time, presence of TRPC1, TRPC3, TRPC4 and TRPC6
mRNA in MG-63 cells, although neither TRPC5 nor TRPC7 were detected by RT-PCR on
isolated mRNA. On the basis of sequence homology and functional similarities, members of the
mammalian TRPC family can be divided into four subfamilies: TRPC1, TRPC2, TRPC3/6/7 and
TRPC4/5, and in humans, TRPC2 is a pseudogene (Wes et al. 1995). It should be noted that
expression of at least one member of each subfamily was revealed in MG-63 cells. Both TRPC1
and TRPC4 have been shown to form SOCC (Liu et al. 2003; Wang et al. 2004). TRPC3 at
endogenous low-level expression behave as store-operated cation channels (Trebak et al. 2003).
In contrast, overexpression of TRPC3 led to currents that correspond to the receptor-operated
cation channel pattern. Substantial evidence has indicated that TRPC6 is more likely to be a
receptor-operated cation channel activated by the diacylglycerol, and insensitive towards store
depletion (Boulay et al. 1997; Hofmann et al. 1999; Trebak et al. 2003). Nevertheless, complexity
in functional characterization of TRPCs arises from the fact that TRPCs can exist as homo- and
hetero-tetramers, both in vivo and when heterologously expressed (Birnbaumer et al. 1996;
Clapham et al. 2001). Therefore, we suggest that TRPC channels expressed in MG-63 cells
might be responsible of CCE and be further involved in osteoblastic cell proliferation. This
would be consistent with other studies in which a similar implication of TRPCs in cell prolifer-
ation has been observed (Golovina et al. 2001; Sweeney et al. 2002). Further studies are
warranted in order to establish exactly which TRPC is involved in the CCE of osteoblasts.
Interestingly, Maroto et al. (2005) have reported that TRPC1 forms a stretch-activated channel.
Such stretch-activated ion channels have been associated with mechanotransduction and
mechanical loading has been shown to be essential for skeletal homeostasis and bone formation
(Duncan & Turner 1995; Harada & Rodan 2003). In this respect, osteoblasts are directly acti-
vated by loading, and influx of extracellular Ca2+ has been shown to play a significant role in
the early response of osteoblasts, such as increased proliferation, differentiation and matrix
synthesis, to mechanical stimuli (Walker et al. 2000; Ziros et al. 2002; Danciu et al. 2003).
One hypothesis of ageing proposes that age-dependent, subtle dysregulation of Ca2+
homeostasis, resulting in small changes of intracellular Ca2+-free concentration sustained over
extended period of time, would account for age-related changes in cellular function (Khachaturian
1989). Accordingly, Huang et al. (2000) have reported that defects in the IP3-mediated Ca
2+
release pathway contribute to deficient Ca2+ signalling in cells undergoing replicative senescence,
with endogenous Ca2+ store depletion. With regard to bone metabolism, Zahanich et al. (2005)
have shown that in the majority of human cells of the osteoblastic lineage, Ca2+ entry through
the plasma membrane is mediated by channels other than VDCCs. Our results are in agreement
with the importance of other channels, likely to be TRPCs, in osteoblasts, especially in cell
proliferation. Because some studies have demonstrated that ageing is associated with a defect
in proliferation of cells of the osteoblastic lineage, further studies on the alteration of CCE and
an ageing-associated defect in osteoblast proliferation seem promising.
In this study, we have demonstrated for the first time, the presence of CCE in human
osteoblast-like MG-63 cells, which is inhibited by SOCC antagonists. We also demonstrated the
expression of TRPC1, 3, 4 and 6 in these cells, some of which have been implicated in CCE
in other cell types. Inhibition of CCE here lengthened the cell cycle time and reduced cell
proliferation rate. Taken together, our results suggest that stimulation of osteoblast proliferation
is associated with induction of CCE more likely being attributable to TRPC channels. The results
shed light on a possible new signalling pathway controlling transition from stationery to
proliferative population growth in osteoblasts involving members of the TRPC channel family.
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Therefore, these findings could be of great importance in revealing the mechanism associated
with osteoblastic proliferation in order to understand its importance in pathophysiology, such as
in osteoporosis, and could lead to new insights in the development of treatment.
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